Makasasa, Sittie Hanah O.
HRN: 28-23-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2025
CEFUROXIME 750MG (VIAL)
12/08/2025
12/15/2025
IV
220mg
Q8hours
PCAP-C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes